Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Plenary Session 4206

New Advances in Ataxia

Wednesday, October 7, 2026
10:30 - 12:00 | Grand Ballroom, Level 1

In this session, the faculty will highlight key developments spanning the genetic landscape of adult- and pediatric-onset ataxias, the identification of biomarkers for disease progression, and emerging insights into molecular mechanisms and therapeutic targets.

Chairs:

Niccolo Mencacci, USA
Bart Van De Warrenburg, Netherlands

Presenters:

Recently Discovered Genetic Ataxias

Biomarkers of Disease Progression in Ataxias

Molecular Mechanisms and Emerging Therapeutic Strategies
Alexandra Durr, France

CSPC Liaison(s):

Niccolo Mencacci, USA

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Describe recent advances in the genetic characterization of pediatric and adult-onset ataxias
  2. Identify key fluid, imaging, and clinical markers for tracking disease progression in ataxias
  3. Describe the molecular and cellular pathways implicated in cerebellar degeneration and discuss how these insights are guiding treatment development

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Intermediate / Experienced